GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
Oct 9, 2024 — GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
Zantac Lawsuit: Status, Eligibility, & Settlements - Drugwatch
Nov 1, 2024 — People who took Zantac made with ranitidine and developed cancer filed lawsuits after manufacturers issued ranitidine and Zantac recalls for the potential risk of cancer. FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen.
Zantac maker GSK agrees to pay $2.3 bn in US settlements
Oct 9, 2024 — British pharmaceutical company GSK said Wednesday it has agreed to pay $2.3 billion in the United States to put an end to lawsuits alleging that its Zantac heartburn drug caused cancer.
FDA Requests Removal of All Ranitidine Products (Zantac) from …
The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.
GSK shares tumble after Delaware court ruling on Zantac - Financial Times
Jun 3, 2024 — GSK shares dropped almost 10 per cent on Monday after a ruling from a Delaware judge left the UK drugmaker exposed to US jury trials over its allegedly carcinogenic heartburn treatment Zantac.
Delaware top court will hear drugmakers' appeal to end Zantac …
Aug 27, 2024 — Delaware's highest court said on Tuesday it will hear an appeal by GSK and other drugmakers seeking to end more than 70,000 lawsuits claiming discontinued heartburn drug Zantac caused cancer.
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by …
Jul 1, 2024 — A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.
GSK set to face jury trials over heartburn drug Zantac - Financial Times
Jun 1, 2024 — The ruling by Judge Vivian Medinilla means that scientific experts will be able to testify before a jury that there is a link between the plaintiffs’ cancers and their exposure to NDMA, a probable...
Legal Bay Presettlement Funding Reports Settlement
5 days ago — If you're a plaintiff in an active GSK Zantac lawsuit and need an immediate cash advance from your anticipated settlement, please visit the company's website HERE or call 877.571.0405 where agents ...
After Delaware decision, GSK faces $2B to settle Zantac lawsuits
Jun 3, 2024 — The decision of a Delaware judge on Friday to allow more than 75,000 Zantac lawsuits to go forward to jury trials has left four major drugmakers—GSK, Pfizer, Sanofi and Boehringer...